clinicaltrials.gov rank 87 |
Number of domains linking to clinicaltrials.gov 61 | semantic flow 12.02 |
Number of links to clinicaltrials.gov 166 | semantic flow 12.02 |
Number of domains linked from clinicaltrials.gov 2 | semantic flow 3.18 |
Number of links from clinicaltrials.gov 72 | semantic flow 3.18 |
Pages with highest topical PageRank pointing to domain.
On-topic pages from domain with highest topical PageRank.
title / url | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | |
---|---|---|---|---|---|---|---|---|---|
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) https://clinicaltrials.gov/ct2/show/NCT01966289 ![]() | 0.28 | 0.99 | 57 | 6 | 2 | 1 | 1 | 1 | |
Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers - Full Text View - https://clinicaltrials.gov/ct2/show/NCT03114501 ![]() | 0.28 | 0.73 | 60 | 10 | 5 | 2 | 1 | 1 | |
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation - Full Text View - ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02906943 ![]() | 0.28 | 0.93 | 55 | 6 | 2 | 1 | 1 | 1 | |
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) - Full Text View - https://clinicaltrials.gov/ct2/show/NCT01958021 ![]() | 0.21 | 0.6 | 61 | 8 | 4 | 2 | 1 | 1 | |
A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or https://clinicaltrials.gov/ct2/show/NCT01968213 ![]() | 0.21 | 0.81 | 61 | 9 | 5 | 2 | 1 | 1 | |
AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer - Full Text View - ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/study/NCT01445418?cond=Familial+cancer+of+breast&rank= ![]() | 0.19 | 0.99 | 73 | 15 | 8 | 3 | 0 | 0 | |
Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients - Full Text View - ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03342417 ![]() | 0.19 | 1 | 66 | 14 | 10 | 3 | 1 | 1 | |
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor https://www.clinicaltrials.gov/ct2/show/NCT01358877?term=APHINITY&rank=1 ![]() | 0.19 | 0.56 | 63 | 8 | 4 | 2 | 1 | 1 | |
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer - Full Text View - ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT01946204 ![]() | 0.18 | 0.66 | 57 | 7 | 4 | 2 | 1 | 1 | |
Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer - Full Text View - ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02422979 ![]() | 0.18 | 0.73 | 55 | 5 | 2 | 1 | 1 | 1 |
Relevant domains with most links to selected domain.
Relevant domains with most links from selected domain.
domain ![]() | ![]() | ![]() | |
---|---|---|---|
http://nih.gov/ ![]() | 44 | 2.32 | nih.gov |
http://medlineplus.gov/ ![]() | 28 | 0.86 | medlineplus.gov |
Pages from domain with most relevant inbound links.
url | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://clinicaltrials.gov/ ![]() | 2 | 0.16 | 0.97 | 0.12 | -1 | no | -1 | -1 | -1 | -1 | 2 | 2 | |
https://clinicaltrials.gov/search/open/condition=neoplasms+%22quality+of+life%22 ![]() | 1 | 0.15 | 0.98 | 0.07 | 0.98 | yes | 100 | 46 | 0 | 0 | 1 | 1 | |
https://clinicaltrials.gov/ct2/show/NCT03342417 ![]() | 1 | 0.19 | 0.94 | 0.07 | 1 | yes | 66 | 14 | 10 | 3 | 1 | 1 | |
https://www.clinicaltrials.gov/ct2/show/study/NCT02068092 ![]() | 1 | 0.15 | 0.97 | 0.07 | 0.87 | yes | 61 | 8 | 4 | 2 | 1 | 1 | |
https://clinicaltrials.gov/ct2/show/NCT02672865 ![]() | 1 | 0.16 | 0.93 | 0.07 | 0.61 | yes | 60 | 10 | 5 | 2 | 1 | 1 | |
https://clinicaltrials.gov/ct2/show/NCT01839487 ![]() | 1 | 0.15 | 0.92 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 1 | 1 | |
https://www.clinicaltrials.gov/ct2/info/fdalinks ![]() | 1 | 0.17 | 0.84 | 0.05 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.clinicaltrials.gov/ct2/help/for-patient ![]() | 1 | 0.17 | 0.83 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.clinicaltrials.gov/ct2/about-site/terms-conditions ![]() | 1 | 0.17 | 0.66 | 0.04 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.clinicaltrials.gov/ct2/resources ![]() | 1 | 0.17 | 0.46 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://clinicaltrials.gov/search?recr=open&cond=cancer&intr=immunotherapy ![]() | 49 | 0.16 | 0.96 | 3.55 | 1 | yes | 100 | 51 | 0 | 0 | 1 | 1 | |
https://clinicaltrials.gov/search/open/condition=neoplasms+%22quality+of+life%22 ![]() | 43 | 0.15 | 0.98 | 2.81 | 0.98 | yes | 100 | 46 | 0 | 0 | 1 | 1 | |
https://clinicaltrials.gov/search?recr=open&cond=neoplasms&age=0 ![]() | 13 | 0.15 | 0.94 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 1 | 1 | |
https://clinicaltrials.gov/ct2/show/NCT02672865 ![]() | 9 | 0.16 | 0.93 | 0.29 | 0.61 | yes | 60 | 10 | 5 | 2 | 1 | 1 | |
https://www.clinicaltrials.gov/ct2/show/study/NCT02068092 ![]() | 8 | 0.15 | 0.97 | 0.36 | 0.87 | yes | 61 | 8 | 4 | 2 | 1 | 1 | |
https://clinicaltrials.gov/ct2/show/NCT01042379 ![]() | 8 | 0.15 | 0.97 | 0.09 | -1 | no | -1 | -1 | -1 | -1 | 1 | 1 | |
https://clinicaltrials.gov/ct2/show/NCT03375983?recrs=abc&cond=cancer&intr=immunotherapy&r ![]() | 3 | 0.15 | 0.92 | 0.09 | 0.62 | yes | 68 | 5 | 0 | 0 | 0 | 0 | |
https://clinicaltrials.gov/ct2/show/NCT02849314?recrs=abc&cond=cancer&intr=immunotherapy&r ![]() | 1 | 0.15 | 0.92 | 0.04 | 0.82 | yes | 58 | 6 | 2 | 1 | 0 | 0 | |
https://clinicaltrials.gov/ct2/show/NCT01839487 ![]() | 1 | 0.15 | 0.92 | 0 | -1 | no | -1 | -1 | -1 | -1 | 1 | 1 | |
https://clinicaltrials.gov/search?recr=open&cond=neoplasms&intr=complementary+and+alternat ![]() | 1 | 0.15 | 0.97 | 0 | -1 | no | -1 | -1 | -1 | -1 | 1 | 1 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.